Pneumocystis jirovecii multilocus gene sequencing: Findings and implications

Future Microbiology

Volumn 5, Issue 8, 2010, Pages 1257-1267

  Matos, Olga ^a   Esteves, Francisco ^a  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

clinical course; diversity; genotype; multilocus approach; Pneumocystis jirovecii

Indexed keywords

COTRIMOXAZOLE; DAPSONE; PYRIMETHAMINE SULFADIAZINE; RIBOSOME RNA; SULFANILAMIDE DERIVATIVE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL TRANSMISSION; CLONAL VARIATION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HUMAN; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REINFECTION; REVIEW;

DNA FINGERPRINTING; DNA, FUNGAL; GENES, FUNGAL; GENETIC VARIATION; GENOTYPE; HUMANS; MOLECULAR EPIDEMIOLOGY; MYCOLOGICAL TYPING TECHNIQUES; PNEUMOCYSTIS INFECTIONS; PNEUMOCYSTIS JIROVECII; SEQUENCE ANALYSIS, DNA;

PNEUMOCYSTIS JIROVECII;

EID: 77955944420     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.75     Document Type: Review

References (87)

1. Stringer JR, Beard CB, Miller RF, Wakefield AE: A new name (Pneumocystis jirovecii) for Pneumocystis from humans. Emerg. Infect. Dis. 8, 891-896 (2002).
2. Redhead SA, Cushion MT, Frenkel JK, Stringer JR: Pneumocystis and Trypanosoma cruzi: nomenclature and typifications. J. Eukaryot. Microbiol. 53, 2-11 (2006).
3. Wakefield AE: Pneumocystis carinii. Br. Med. Bull. 61, 175-188 (2002).
4. Sepkowitz KA: Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin. Infect. Dis. 34, 1098-1107 (2002).
5. Kaneko Y, Suwa A, Ikeda Y, Hirakata M: Pneumocystisjiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature. Rheumatology 16, 36-38 (2006).
6. Poppers DM, Scherl EJ: Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care. IBD 14(1), 106-113 (2008).
7. Matos O, Costa MC, Correia I et al.: Pneumocystis jirovecii carriage in Portuguese immunocompetent patients: preliminary results. J. Eukaryot. Microbiol. 50(Suppl.), 647-648 (2003).
8. Montes-Cano MA, de la Horra C, Martin-Juan J et al.: Pneumocystis jiroveci genotypes in the Spanish population. Clin. Infect. Dis. 39, 123-128 (2004).
9. Morris A, Sciurba FC, Lebedeva IP et al.: Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am. J. Respir. Crit. Care Med. 170(4), 408-413 (2004).
10. Matos O, Costa MC, Correia I et al.: Pneumocystis jiroveci infection in immunocompetent patients with pulmonary disorders, in Portugal. Acta Med. Port. 19, 121-126 (2006).
11. Medrano FJ, Montes-Cano M, Conde M et al.: Pneumocystis jirovecii in general population. Emerg. Infect. Dis. 11, 245-250 (2005).
12. Crothers K, Beard CB, Turner J et al.: Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 19, 801-805 (2005).
13. Valerio A, Tronconi E, Mazza F, Cargnel A, Fantoni G, Atzori C: DHPS-mutated isolates of Pneumocystis jirovecii from HIV-positive individuals: analysis of related ITS genotypes. J. Eukaryot. Microbiol. 53(Suppl. 1), S108-S109 (2006).
14. Valerio A, Tronconi E, Mazza F et al.: Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype. J. Acquir. Immune Defic. Syndr. 45(5), 521-528 (2007).
15. Radhi S, Alexander T, Ukwu M, Saleh S, Morris A. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003. BMC Infect. Dis. 8, 118 (2008).
16. Walzer PD, Evans HE, Copas AJ, Edwards SG, Grant AD, Miller RF: Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-positive patients: 1985-2006. Clin. Infect. Dis. 46, 625-633 (2008).
17. Alvarez-Martinez MJ, Moreno A, Miro JM et al.: Pneumocystis jirovecii pneumonia in Spanish HIV-positive patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality. Diagn. Microbiol. Infect. Dis. 62(1), 34-43 (2008).
18. van Hal SJ, Gilgado F, Doyle T et al.: Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes. J. Clin. Microbiol. 47(6), 1818-1823 (2009).
19. Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lundgren B: Effects of mutations in Pneumocystis carinii dihydropteroate synthase on outcome of AIDS-associated P. carinii pneumonia. Lancet 354, 1347-1351 (1999).
20. Olsson M, Lidman C, Latouche S et al.: Identification of Pneumocystis carinii f. sp. hominis gene sequences in filtered air in hospital environments. J. Clin. Microbiol. 36(6), 1737-1740 (1998).
21. Miller RF, Wakefield AE: Pneumocystis carinii genotypes and severity of pneumonia. Lancet 353(9169), 2039-2040 (1999).
22. Armstrong W, Meshnick S, Kazanjian P: Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients. Microbes Infect. 2, 61-67 (2000).
23. Huang L, Beard CB, Creasman J et al.: Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J. Infect. Dis. 182, 1192-1198 (2000).
24. Hauser PM, Blanc DS, Sudre P et al.: Genetic diversity of Pneumocystis carinii in HIV-positive and -negative patients as revealed by PCR-SSCP typing. AIDS 15(4), 461-466 (2001).
25. Thomas CF Jr, Limper AH: Current insights into the biology and pathogenesis of Pneumocystis pneumonia. Nat. Rev. Microbiol. 5(4), 298-308 (2007).
26. Miller RF, Evans HE, Copas AJ, Cassell JA: Climate and genotypes of Pneumocystis jirovecii. Clin. Microbiol. Infect. 13(4), 445-448 (2007).
27. Esteves F, Gaspar J, Marques T et al.: Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data. Clin. Microbiol. Infect. 16, 878-884 (2010).
28. Edlind TD, Bartlett MS, Weinberg GA, Prah GN, Smith JW. The p-tubulin gene from rat and human isolates of Pneumocystis carinii. Mol. Microbiol. 6(22), 3365-3373 (1992).
29. Stringer JR, Stringer SL, Zhang J, Baughman R, Smulian AG, Cushion MT: Molecular genetic distinction of Pneumocystis carinii from rats and humans. J. Eukaryot. Microbiol. 40(6), 733-741 (1993).
30. Wakefield AE, Lindley AR, Ambrose HE, Denis CM, Miller RF: Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients. J. Infect. Dis. 187, 901-908 (2003).
31. Hauser PM, Sudre P, Nahimana A, Francioli P, and the Study Group: Prophylaxis failure is associated with a specific Pneumocystis carinii genotype. Clin. Infect. Dis. 33, 1080-1082 (2001).
32. Beard CB, Carter JL, Keely SP et al.: Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg. Infect. Dis. 6, 265-272 (2000).
33. Costa MC, Esteves F, Antunes F, Matos O: Multilocus genotyping of Pneumocystis jirovecii in immunocompromised patients: preliminary results. J. Eukaryot. Microbiol. 53 Suppl 1, S104-S105 (2006).
34. Beard CB, Roux P, Nevez G et al.: Strain typing methods and molecular epidemiology of Pneumocystis pneumonia. Emerg. Infect. Dis. 10, 1729-1735 (2004).
35. Hunter JA, Wakefield AE: Genetic divergence at the mitochondrial small subunit ribosomal RNA gene among isolates of Pneumocystis carinii from five mammalian host species. J. Eukaryot. Microbiol. 43(5), S24-S25 (1996).
36. Wakefield AE, Peters SE, Banerji S: Pneumocystis carinii shows DNA homology with the ustomycetous red yeast fungi. Mol. Microbiol. 6(14), 1903-1911 (1992).
37. Walker DJ, Wakefield AE, Dohn MN et al.: Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure. J. Infect. Dis. 178(6), 1767-1775 (1998).
38. Liu Y, Rocourt M, Pan S, Liu C, Leibowitz MJ: Sequence and variability of the 5.8S and 26S rRNA genes of Pneumocystis carinii. Nucleic Acids Res. 20(14), 3763-3772 (1992).
39. Lu JJ, Bartlett MS, Shaw MM: Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. J. Clin. Microbiol. 32(12), 2904-2912 (1994).
40. Denis CM, Mazars E, Guyot K: Genetic divergence at the SODA locus of six different formae speciales of Pneumocystis carinii. Med. Mycol. 38(4), 289-300 (2000).
41. Kutty G, Huang SN, Kovacs JA: Characterization of thioredoxin reductase genes (trr1) from Pneumocystis carinii and Pneumocystis jiroveci. Gene 310, 175-183 (2003).
42. Mazars E, Odberg-Ferragut C, Dei-Cas E et al.: Polymorphism of the thymidylate synthase gene of Pneumocystis carinii from different host species. J. Eukaryot. Microbiol. 42(1), 26-32 (1995).
43. Banerji S, Lugli EB, Miller RF, Wakefield AE: Analysis of genetic diversity at the arom locus in isolates of Pneumocystis carinii. J. Eukaryot. Microbiol. 42(6), 675-679 (1995).
44. Kaiser K, Rabodonirina M, Mayencon M, Picot S: Cdc2 gene of Pneumocystis carinii hominis and its expression during culture. J. Eukaryot. Microbiol. 46(5), S130 (1999).
45. Ma L, Borio L, Masur H, Kovacs JA: Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J. Infect. Dis. 180(6), 1969-1978 (1999).
46. Garbe TR, Stringer JR: Molecular characterization of clustered variants of genes encoding major surface antigens of human Pneumocystis carinii. Infect. Immun. 62(8), 3092-3101 (1994).
47. Wada M, Nakamura Y: Unique telomeric expression site of major-surface-glycoprotein genes of Pneumocystis carinii. DNA Res. 3(2), 55-64 (1996).
48. Esteves F, Tavares A, Costa MC, Gaspar J, Antunes F, Matos O: Genetic characterization of the UCS and Kex1 loci of Pneumocystis jiroveci. Eur. J. Clin. Microbiol. Infect. Dis. 28(2), 175-178 (2009).
49. Kutty G, Kovacs JA: A single-copy gene encodes Kex1, a serine endoprotease of Pneumocystis jiroveci. Infect. Immun. 71(1), 571-574 (2003).
50. Kutty G, Hernandez-Novoa B, Czapiga M, Kovacs JA: Pneumocystis encodes a functional s-adenosylmethionine synthetase gene. Eukaryot Cell. 7(2), 258-267 (2008).
51. Stedman TT, Buck GA: Identification, characterization, and expression of the BiP endoplasmic reticulum resident chaperonins in Pneumocystis carinii. Infect Immun. 64(11), 4463-4471 (1996).
52. Villegas LR, Kottom TJ, Limper AH; Characterization of PCEng2 a p-1,3-endoglucanase homologue in Pneumocystis carinii with activity in cell wall regulation. Am. J. Respir. Cell Mol. Biol. 43(2), 192-200 (2010).
53. Miller RF, Lindley AR, Ambrose HE, Aliouat-Denis CM, Wakefield AE: Multilocus genotyping of Pneumocystis jirovecii from adult HIV-positive patients with Pneumocystis pneumonia. J.Eukaryot. Microbiol. 50(Suppl.), 654-655 (2003).
54. Hauser PM, Francioli P, Bille J, Telenti A, Blanc DS: Typing of Pneumocystis carinii f. sp. hominis by single-strand conformation polymorphism of four genomic regions. J. Clin. Microbiol. 35(12), 3086-3091 (1997).
55. Nahimana A, Blanc DS, Francioli P, Bille J, Hauser PM: Typing of Pneumocystis carinii f. sp. hominis by PCR-SSCP to indicate a high frequency of co-infections. J. Med. Microbiol. 49(8), 753-758 (2000).
56. Volpe G, Sbaiz L, Avanzini C, Caramello P, Savoia D: Genetic diversity of Pneumocystis carinii isolated from human immunodeficiency virus-positive patients in Turin, Italy. J. Clin. Microbiol. 39(8), 2995-2998 (2001).
57. Latouche S, Ortona E, Mazars E et al.: Biodiversity of Pneumocystis carinii hominis: typing with different DNA regions. J. Clin. Microbiol. 35(2), 383-387 (1997).
58. Esteves F, Gaspar J, Tavares A et al.: Population structure of Pneumocystis jirovecii isolated from immunodeficiency virus-positive patients. Infect. Genet. Evol. 10, 192-199 (2010).
59. Matos O, Lee CH, Jin S et al.: Pneumocystis jiroveci in Portuguese immunocompromised patients: association of specific ITS genotypes with treatment failure, bad clinical outcome and childhood. Infect. Genet. Evol. 3(4), 281-285 (2003).
60. Meshnick SR, Hossler PA, Enger KS: Distribution of DHPS mutations among ITS subtypes of P. carinii f. sp. hominis. J. Eukaryot. Microbiol. (Suppl.), S126-S128 (2001).
61. Esteves F, Montes-Cano MA, de la Horra C et al.: Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin. Microbiol. Infect. 14(4), 356-362 (2008).
62. Costa MC, Helweg-Larsen J, Lundgren B, Antunes F, Matos O: Mutations in the dihydropteroate synthase gene of Pneumocystis jiroveci isolates from Portuguese patients with Pneumocystis pneumonia. Int. J. Antimicrob. Agents 22(5), 516-520 (2003).
63. Kazanjian P, Locke AB, Hossler PA et al.: Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS 12, 873-878 (1998).
64. Smith JM, Smith NH, O'Rourke M, Spratt BG: How clonal are bacteria? Proc. Natl Acad. Sci. USA 90, 4384-4388 (1993).
65. Keely SP, Stringer JR, Baughman RP, Linke MJ, Walzer PD, Smulian AG: Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis. J. Infect. Dis. 172, 595-598 (1995).
66. Keely SP, Baughman RP, Smulian AG, Dohn MN, Stringer JR: Source of Pneumocystis carinii in recurrent episodes of pneumonia in AIDS patients. AIDS 10, 881-888 (1996).
67. Keely SP, Stringer JR: Sequences of Pneumocystis carinii f. sp. hominis strains associated with recurrent pneumonia vary at multiple loci. J. Clin. Microbiol. 35, 2745-2747 (1997).
68. Tsolaki AG, Beckers P, Wakefield AE: Pre-AIDS era isolates of Pneumocystis carinii f. sp. hominis: high genotypic similarity with contemporary isolates. J. Clin. Microbiol. 36, 90-93 (1998).
69. Vargas SL, Hughes WT, Santolaya ME et al.: Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin. Infect. Dis. 32, 855-861 (2001).
70. Vargas SL, Ponce CA, Sanchez CA, Ulloa AV, Bustamante R, Juarez G: Pregnancy and asymptomatic carriage of Pneumocystis jiroveci. Emerg. Infect. Dis. 9, 605-606 (2003).
71. Miller RF, Lindley AR, Ambrose HE, Malin AS, Wakefield AE: Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom. Antimicrob. Agents Chemother. 47, 3979-3981 (2003).
72. Beard CB, Fox MR, Lawrence GG et al.: Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: epidemiological implications. J. Infect. Dis. 192(10), 1815-1818 (2005).
73. Hocker B, Wendt C, Nahimana A, Tonshoff B, Hauser PM: Molecular evidence of Pneumocystis transmission in pediatric transplant unit. Emerg. Infect. Dis. 11(2), 330-332 (2005).
74. Miller RF, Ambrose HE, Novelli V, Wakefield AE: Probable mother-to-infant transmission of Pneumocystis carinii f. sp. hominis infection. J. Clin. Microbiol. 40(4), 1555-1557 (2002).
75. Rabodonirina L, Vanhems P, Couray-Targe S et al.: Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant reciepients hospitalized with HIV-positive patients. Emerg. Infect. Dis. 10, 1766-1773 (2004).
76. Gianella S, Haeberli L, Joos B et al.: Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients. Transpl. Infect. Dis. 12, 1-10 (2010).
77. Montes-Cano MA, Chabe M, Fontillon-Alberdi M et al.: Vertical transmission of Pneumocystis jirovecii in humans. Emerg. Infect. Dis. 15, 125-127 (2009).
78. Totet A, Latouche S, Duwat H et al.: Multilocus genotyping of Pneumocystis jirovecii in patients developing diverse forms of parasitism: implication for a wide human reservoir for the fungus. J. Eukaryot. Microbiol. 50(Suppl.), 670-671 (2003).
79. Totet A, Duwat H, Magois E et al.: Similar genotypes of Pneumocystis jirovecii in different forms of Pneumocystis infection. Microbiology 150, 1173-1178 (2004).
80. Kazanjian P, Armstrong W, Hossler PA et al.: Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS. J. Infect. Dis. 183, 819-822 (2001).
81. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H: Guidelines for prevention and treatment of opportunistic infections in HIV-positive adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recommend. Rep. 58(RR-4), 1-207 (2009).
82. Santos LD, Lacube P, Latouche S et al.: Contribution of dihydropteroate synthase gene typing for Pneumocystis carinii f.sp. hominis epidemiology. J. Eukaryot. Microbiol. 46, S133-S134 (1999).
83. Ma L, Kovacs JA: Genetic analysis of multiple loci suggests that mutations in the Pneumocystis carinii f. sp. hominis dihydropteroate synthase gene arose independently in multiple strains. Antimicrob. Agents Chemother. 45, 3213-3215 (2001).
84. Takahashi T, Kanda T, Iwamoto A: Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan. Res. Commun. Mol. Pathol. Pharmacol. 112, 159-176 (2002).
85. Nahimana A, Rabodonirina M, Bille J, Francioli P, Hauser PM. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Antimicrob. Agents Chemother. 48(11), 4301-4305 (2004).
86. Siripattanapipong S, Leelayoova S, Mungthin M, Worapong J, Tan-Ariya P: Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-positive patients. Med. Mycol. 46(4), 389-392 (2008).
87. Lee C, Helweg-Larsen J, Tang X et al.: Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J. Clin. Microbiol. 36, 734-741 (1998).